U.S. drug retailer Walgreens Boots Alliance Inc. teamed up with Alphabet Inc.-owned Verily Life Sciences LLC to collaborate on new projects aimed at improving health outcomes for patients with chronic conditions.
California-based Verily is a life sciences research and engineering organization that develops platforms to collect and organize health data for holistic care management.
According to a Dec. 19 announcement., Walgreens will become Verily's first-choice retail pharmacy development and commercialization partner. The companies will explore ways to improve access to advanced healthcare technologies and solutions, which may include sensors and software to help prevent, manage, screen and diagnose disease.
In addition, Walgreens will work with Onduo, Verily's joint venture with France's Sanofi, to launch a virtual diabetes solution to Walgreens employees and family members with Type 2 diabetes.